(Q43092680)

13 November 2017

Suppression of the inflammatory cascade is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis (English)

1 reference

13 November 2017

0 references

1 reference

Anupam Bishayee

1

1 reference

13 November 2017

Abhijeet Waghray

2

1 reference

13 November 2017

Kendra F Barnes

3

1 reference

13 November 2017

Thomas Mbimba

4

1 reference

13 November 2017

Deepak Bhatia

5

1 reference

13 November 2017

Malay Chatterjee

6

1 reference

13 November 2017

Altaf S Darvesh

7

1 reference

13 November 2017

20 April 2010

1 reference

13 November 2017

Pharmaceutical Research

1 reference

13 November 2017

27

1 reference

13 November 2017

6

1 reference

13 November 2017

1080-1091

1 reference

Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules

13 November 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11095-010-0144-4

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

21 January 2018

1 reference

12 December 2020

Role of the heat shock response and molecular chaperones in oncogenesis and cell death

1 reference

12 December 2020

Influence of dietary resveratrol on early and late molecular markers of 1,2-dimethylhydrazine-induced colon carcinogenesis

1 reference

12 December 2020

Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study .

1 reference

12 December 2020

Chemoprevention of hepatocellular carcinoma: concept, progress and perspectives.

1 reference

12 December 2020

The correlation between cyclooxygenase-2 expression and hepatocellular carcinogenesis.

1 reference

12 December 2020

NF-kappaB in liver diseases: a target for drug therapy

1 reference

12 December 2020

Human cyclooxygenase-2 cDNA

1 reference

12 December 2020

Expressions of HSP70 and HSP27 in hepatocellular carcinoma

1 reference

12 December 2020

Concomitant overexpression of heat-shock protein 70 and HLA class-I in hepatitis C virus-related hepatocellular carcinoma.

1 reference

12 December 2020

Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.

1 reference

12 December 2020

Hepatocellular carcinoma: epidemiology, risk factors, and screening

1 reference

12 December 2020

Multitargeted cancer prevention by quercetin

1 reference

12 December 2020

Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis

1 reference

12 December 2020

Hepatocellular carcinoma--epidemiological trends and risk factors

1 reference

12 December 2020

Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis

1 reference

12 December 2020

Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms

1 reference

12 December 2020

Relevance of nitrosamines to human cancer

1 reference

12 December 2020

Global cancer statistics, 2002

1 reference

12 December 2020

Cyclooxygenases in hepatocellular carcinoma.

1 reference

12 December 2020

Pterostilbene is equally potent as resveratrol in inhibiting 12-O-tetradecanoylphorbol-13-acetate activated NFkappaB, AP-1, COX-2, and iNOS in mouse epidermis.

1 reference

12 December 2020

Induction of heat shock gene expression without heat shock by hepatocarcinogens and during hepatic regeneration in rat liver

1 reference

12 December 2020

Resveratrol addiction: to die or not to die.

1 reference

12 December 2020

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

1 reference

12 December 2020

Resveratrol prevents fibrosis, NF-kappaB activation and TGF-beta increases induced by chronic CCl4 treatment in rats

1 reference

12 December 2020

Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase.

1 reference

12 December 2020

The IkappaB kinase - a bridge between inflammation and cancer

1 reference

12 December 2020

Cyclooxygenase-2 in hepatocellular carcinoma

1 reference

12 December 2020

Cyclooxygenase-2 and carcinogenesis

1 reference

12 December 2020

Comprehensive review of cancer chemopreventive agents evaluated in experimental carcinogenesis models and clinical trials

1 reference

12 December 2020

Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas

1 reference

12 December 2020

Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials

1 reference

12 December 2020

Hepatocellular carcinoma

1 reference

12 December 2020

Lack of influence of cyclooxygenese-2 expression in hepatocellular carcinomas on patient survival

1 reference

12 December 2020

Hepatocarcinogenesis: a dynamic cellular perspective.

1 reference

12 December 2020

Regulation of inflammation and redox signaling by dietary polyphenols

1 reference

12 December 2020

Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia

1 reference

12 December 2020

Significance of wine and resveratrol in cardiovascular disease: French paradox revisited

1 reference

12 December 2020

Bioactive food components, inflammatory targets, and cancer prevention

1 reference

12 December 2020

Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells: pivotal roles of NF-kappaB and MAPK.

1 reference

12 December 2020

Hepatocellular carcinoma: recent trends in the United States

1 reference

12 December 2020

Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis

1 reference

12 December 2020

Roxithromycin inhibits constitutive activation of nuclear factor {kappa}B by diminishing oxidative stress in a rat model of hepatocellular carcinoma

1 reference

12 December 2020

Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis

1 reference

12 December 2020

Experimental models of hepatocellular carcinoma: developments and evolution

1 reference

12 December 2020

Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma.

1 reference

12 December 2020

Resveratrol inhibits N-nitrosodiethylamine-induced ornithine decarboxylase and cyclooxygenase in mice

1 reference

12 December 2020

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

1 reference

12 December 2020

NF-kappaB at the crossroads of life and death

1 reference

12 December 2020

Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.

1 reference

12 December 2020

Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials

1 reference

12 December 2020

Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe.

1 reference

12 December 2020

Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?

1 reference

12 December 2020

Involvement of HSP70 in resveratrol-induced apoptosis of human prostate cancer.

1 reference

12 December 2020

Expression pattern of the genes for different members of the heat-shock protein 70 family, ornithine decarboxylase, and c-Ha-ras during the early stages of hepatocarcinogenesis.

1 reference

12 December 2020

Resveratrol induces apoptosis in K562 (chronic myelogenous leukemia) cells by targeting a key survival protein, heat shock protein 70.

1 reference

12 December 2020

Morin regulates the expression of NF-kappaB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma.

1 reference

12 December 2020

Nitric oxide initiates progression of human melanoma via a feedback loop mediated by apurinic/apyrimidinic endonuclease-1/redox factor-1, which is inhibited by resveratrol

1 reference

12 December 2020

Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene

1 reference

12 December 2020

Keap1 eye on the target: chemoprevention of liver cancer

1 reference

12 December 2020

Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation

1 reference

12 December 2020

Cells in stress: transcriptional activation of heat shock genes

1 reference

12 December 2020

Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases.

1 reference

12 December 2020

Resveratrol directly targets COX-2 to inhibit carcinogenesis.

1 reference

12 December 2020

Inflammation and liver cancer: new molecular links .

1 reference

12 December 2020

Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase

1 reference

12 December 2020

Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma

1 reference

12 December 2020

Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives

1 reference

12 December 2020

Molecular targets of dietary agents for prevention and therapy of cancer

1 reference

12 December 2020

Rationale and feasibility of chemoprovention of hepatocellular carcinoma by cyclooxygenase-2 inhibitors

1 reference

12 December 2020

Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis

1 reference

12 December 2020

Anti-inflammatory responses of resveratrol

1 reference

12 December 2020

Silymarin downregulates COX-2 expression and attenuates hyperlipidemia during NDEA-induced rat hepatocellular carcinoma

1 reference

12 December 2020

10.1007/S11095-010-0144-4

Identifiers

DOI

1 reference

13 November 2017

1 reference